TipRanks
Advertisement
Advertisement

DE:0PB Stock Latest News

Closing Bell Movers: Steel Dynamics, Nucor down on pre-announcement
The FlyClosing Bell Movers: Steel Dynamics, Nucor down on pre-announcement
19d ago
AMD
COO
Puma Biotechnology starts Phase 2 study of alisertib in small cell lung cancer
PremiumThe Fly
Puma Biotechnology starts Phase 2 study of alisertib in small cell lung cancer
19d ago
PBYI
Puma Biotechnology Earnings Call Signals Profitable Momentum
PremiumCompany Announcements
Puma Biotechnology Earnings Call Signals Profitable Momentum
2M ago
PBYI
Puma Biotechnology price target raised to $6 from $5 at TD Cowen
PremiumThe Fly
Puma Biotechnology price target raised to $6 from $5 at TD Cowen
2M ago
PBYI
Puma Biotechnology reports Q2 EPS 19c vs 15c last year
PremiumThe Fly
Puma Biotechnology reports Q2 EPS 19c vs 15c last year
2M ago
PBYI
Puma Biotechnology sees Q3 revenue $56M-$59M
PremiumThe FlyPuma Biotechnology sees Q3 revenue $56M-$59M
2M ago
PBYI
Puma Biotechnology raises FY26 revenue to $224M-$231M from $222M-$229M
Premium
The Fly
Puma Biotechnology raises FY26 revenue to $224M-$231M from $222M-$229M
2M ago
PBYI
Is PBYI a Buy, Before Earnings?
Premium
Pre-Earnings
Is PBYI a Buy, Before Earnings?
2M ago
PBYI
Puma Biotechnology Shareholders Back Governance, Reject Warrant Extension
PremiumCompany Announcements
Puma Biotechnology Shareholders Back Governance, Reject Warrant Extension
4M ago
8K
PBYI
Puma Biotechnology Lifts Outlook Despite Q1 Setback
PremiumCompany Announcements
Puma Biotechnology Lifts Outlook Despite Q1 Setback
5M ago
PBYI
Puma Biotechnology Raises Outlook Despite Q1 Reset
PremiumCompany Announcements
Puma Biotechnology Raises Outlook Despite Q1 Reset
5M ago
PBYI
Puma Biotechnology reports Q1 adjusted EPS (4c) vs (10c) last year
PremiumThe Fly
Puma Biotechnology reports Q1 adjusted EPS (4c) vs (10c) last year
5M ago
PBYI
Puma Biotechnology sees Q2 revenue $52M-$55M, one estimate $52M
PremiumThe FlyPuma Biotechnology sees Q2 revenue $52M-$55M, one estimate $52M
5M ago
PBYI
Puma Biotechnology raises FY26 revenue view to $222M-$229M from $214M-$221M
Premium
The Fly
Puma Biotechnology raises FY26 revenue view to $222M-$229M from $214M-$221M
5M ago
PBYI
PBYI Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
PBYI Upcoming Earnings Report: What to Expect?
5M ago
PBYI
Puma Biotechnology Balances Growth, Trials and Profitability
PremiumCompany Announcements
Puma Biotechnology Balances Growth, Trials and Profitability
7M ago
PBYI
Puma Biotechnology reports Q4 EPS 26c vs. 39c last year
PremiumThe Fly
Puma Biotechnology reports Q4 EPS 26c vs. 39c last year
7M ago
PBYI
Puma Biotechnology sees Q1 revenue $38M-$42M, one estimate $49M
PremiumThe Fly
Puma Biotechnology sees Q1 revenue $38M-$42M, one estimate $49M
7M ago
PBYI
PBYI Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PBYI Earnings this Week: How Will it Perform?
7M ago
PBYI
Puma Biotechnology’s Earnings Call: Balancing Growth and Challenges
PremiumCompany AnnouncementsPuma Biotechnology’s Earnings Call: Balancing Growth and Challenges
11M ago
PBYI
Puma Biotechnology Reports Q3 2025 Financial Results
Premium
Company Announcements
Puma Biotechnology Reports Q3 2025 Financial Results
11M ago
PBYI
Cautious Hold Rating for Puma Biotechnology Amid Mixed Financial Signals and Future Uncertainties
Premium
Ratings
Cautious Hold Rating for Puma Biotechnology Amid Mixed Financial Signals and Future Uncertainties
11M ago
PBYI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >